BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2876669)

  • 1. Prevention of duodenal ulcer recurrence.
    Strum WB
    Ann Intern Med; 1986 Nov; 105(5):757-61. PubMed ID: 2876669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of duodenal ulcer with sucralfate.
    Lam SK
    Scand J Gastroenterol Suppl; 1991; 185():22-8. PubMed ID: 1683491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal ulcer. Who should have long-term maintenance therapy?
    Zuckerman G
    Postgrad Med; 1987 Oct; 82(5):52-3, 57-8, 60. PubMed ID: 2890147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of relapse rate on the choice of duodenal ulcer therapy.
    Drug Ther Bull; 1987 Oct; 25(20):77-80. PubMed ID: 2890508
    [No Abstract]   [Full Text] [Related]  

  • 8. Sucralfate maintenance therapy in duodenal ulcer disease. A review.
    Bolin TD
    Am J Med; 1989 Jun; 86(6A):148-51. PubMed ID: 2567571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famotidine in the USA: a review of efficacy studies.
    Gitnick G
    J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE
    Am Fam Physician; 1986 Nov; 34(5):141-4. PubMed ID: 2877559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ranitidine and sucralfate in the long-term treatment of duodenal ulcer.
    Masoero G; Rocchia F; Rossanino A; Marchetto M; Benitti V; De la Pierre M
    J Clin Gastroenterol; 1986 Dec; 8(6):624-7. PubMed ID: 3805657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapy with sucralfate in duodenal ulcer: genuine prevention or accelerated healing of ulcer recurrence?
    Bynum TE; Koch GG
    Am J Med; 1991 Aug; 91(2A):84S-90S. PubMed ID: 1882909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical and surgical prophylaxis for duodenal ulcer, the role of sucralfate.
    Aärimaa M
    Scand J Gastroenterol Suppl; 1987; 127():81-5. PubMed ID: 3303296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.
    Marks IN; Johnston DA; Young GO
    Am J Med; 1991 Aug; 91(2A):95S-101S. PubMed ID: 1882911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duodenal peptic ulcer. Medical therapy].
    Villalobos Pérez JJ
    Rev Gastroenterol Mex; 1984; 49(3):179-84. PubMed ID: 6151237
    [No Abstract]   [Full Text] [Related]  

  • 20. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
    Chen PH; Wang TH; Wang CY; Chen CY; Cheng TC; Tsai YT; Siauw CP; Yang KC; Chen GH; Sung JL
    J Int Med Res; 1989; 17 Suppl 1():25A-31A. PubMed ID: 2566541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.